NRIX
Price
$12.73
Change
+$0.29 (+2.33%)
Updated
Jul 3 closing price
Capitalization
970.48M
4 days until earnings call
RARE
Price
$39.91
Change
+$0.45 (+1.14%)
Updated
Jul 3 closing price
Capitalization
3.77B
25 days until earnings call
Interact to see
Advertisement

NRIX vs RARE

Header iconNRIX vs RARE Comparison
Open Charts NRIX vs RAREBanner chart's image
Nurix Therapeutics
Price$12.73
Change+$0.29 (+2.33%)
Volume$279.64K
Capitalization970.48M
Ultragenyx Pharmaceutical
Price$39.91
Change+$0.45 (+1.14%)
Volume$685.29K
Capitalization3.77B
NRIX vs RARE Comparison Chart in %
Loading...
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NRIX vs. RARE commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRIX is a Hold and RARE is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (NRIX: $12.73 vs. RARE: $39.91)
Brand notoriety: NRIX and RARE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NRIX: 35% vs. RARE: 65%
Market capitalization -- NRIX: $970.48M vs. RARE: $3.77B
NRIX [@Biotechnology] is valued at $970.48M. RARE’s [@Biotechnology] market capitalization is $3.77B. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NRIX’s FA Score shows that 1 FA rating(s) are green whileRARE’s FA Score has 0 green FA rating(s).

  • NRIX’s FA Score: 1 green, 4 red.
  • RARE’s FA Score: 0 green, 5 red.
According to our system of comparison, NRIX is a better buy in the long-term than RARE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NRIX’s TA Score shows that 7 TA indicator(s) are bullish while RARE’s TA Score has 6 bullish TA indicator(s).

  • NRIX’s TA Score: 7 bullish, 3 bearish.
  • RARE’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, NRIX is a better buy in the short-term than RARE.

Price Growth

NRIX (@Biotechnology) experienced а +7.52% price change this week, while RARE (@Biotechnology) price change was +7.52% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

NRIX is expected to report earnings on Jul 10, 2025.

RARE is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RARE($3.77B) has a higher market cap than NRIX($970M). RARE YTD gains are higher at: -5.134 vs. NRIX (-32.431). NRIX has higher annual earnings (EBITDA): -214M vs. RARE (-449.9M). NRIX has more cash in the bank: 550M vs. RARE (494M). NRIX has less debt than RARE: NRIX (26.6M) vs RARE (38.3M). RARE has higher revenues than NRIX: RARE (591M) vs NRIX (56.4M).
NRIXRARENRIX / RARE
Capitalization970M3.77B26%
EBITDA-214M-449.9M48%
Gain YTD-32.431-5.134632%
P/E RatioN/AN/A-
Revenue56.4M591M10%
Total Cash550M494M111%
Total Debt26.6M38.3M69%
FUNDAMENTALS RATINGS
RARE: Fundamental Ratings
RARE
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NRIXRARE
RSI
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
72%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
76%
Bearish Trend 4 days ago
77%
Momentum
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
78%
MACD
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
73%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
72%
Advances
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
76%
Declines
ODDS (%)
Bearish Trend 7 days ago
89%
Bearish Trend 7 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
78%
Aroon
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CMGVX31.520.41
+1.32%
Columbia Select Mid Cap Gro Fd I2
GSTRX10.110.12
+1.20%
Goldman Sachs Strategic Growth R
NQCRX5.460.05
+0.92%
Nuveen Large Cap Value Opportunities I
JAGIX76.620.68
+0.90%
Janus Henderson Growth And Income T
RLECX20.810.16
+0.77%
Russell Inv US Small Cap Equity C

NRIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRIX has been closely correlated with KYMR. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if NRIX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRIX
1D Price
Change %
NRIX100%
+2.33%
KYMR - NRIX
66%
Closely correlated
+0.58%
DNLI - NRIX
59%
Loosely correlated
-1.41%
IDYA - NRIX
59%
Loosely correlated
+0.82%
BEAM - NRIX
56%
Loosely correlated
+0.65%
RNA - NRIX
55%
Loosely correlated
-0.65%
More

RARE and

Correlation & Price change

A.I.dvisor indicates that over the last year, RARE has been loosely correlated with CRNX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if RARE jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RARE
1D Price
Change %
RARE100%
+1.14%
CRNX - RARE
52%
Loosely correlated
+1.22%
DNLI - RARE
51%
Loosely correlated
-1.41%
NRIX - RARE
50%
Loosely correlated
+2.33%
COGT - RARE
50%
Loosely correlated
+2.29%
RVMD - RARE
50%
Loosely correlated
+1.83%
More